Key facts
| Price (PPV) | 55.90 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | vincristine |
| Class | Antineoplastic agents |
| ATC code | L01CA02 |
| Manufacturer | NOVOPHARMA |
| Presentation | Boîte de 1 Flacon de 1 ml |
| Nature | Médicament |
| Hospital price | 34.90 MAD |
| Data collected on | 9/8/2026 |
Indications
La vincristine est généralement utilisée en polychimiothérapie dans les indications suivantes: - induction et consolidation de la rémission de la leucémie aiguë lymphoblastique ; - maladie de Hodgkin ; - lymphomes non hodgkiniens ; - cancer du sein métastatique (traitement palliatif des cas résistants aux traitements usuels) ; - cancer bronchique à petites cellules ; - sarcomes (sarcome ostéogénique, sarcome d’Ewing, rhabdomyosarcome); - tumeur de Wilms ; - neuroblastome. Monothérapie : - purpura thrombopénique idiopathique résistant aux traitements usuels (maladie de Werlhof).
Find an open pharmacy
On-call pharmacies near you
About Pharmacristine 1 mg / 1 ml
Pharmacristine 1 mg / 1 ml belongs to the antineoplastic agents therapeutic class. In Morocco, this drug is marketed by NOVOPHARMA and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Pharmacristine 1 mg / 1 ml, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Pharmacristine 1 mg / 1 ml
Answers to common questions from Moroccan patients about this drug.